Clinical Trial Update: Amyloid Beta-peptide 1-40 and Alzheimer's Disease [NA]

View source ↗

Summary

A clinical trial investigating Amyloid Beta-peptide 1-40 for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Amyloid beta-peptide 1-40

Snippet

Sponsor: CHU de Reims | Conditions: Alzheimer Disease | NA | Status: COMPLETED